Real trials with measurable results
The following case studies illustrate the impact of embedding patient and site insight into clinical trial design across a range of therapeutic areas, trial sizes and development stages.
Delivering an ambitious phase III study
330 sites. 52+ weeks. High symptom burden. Patient and site insight simplified the protocol and strengthened caregiver support, improving trial performance.
Executing a challenging Phase II trial
60 sites. 280 participants. Competing IMPs. Patient insight informed protocol changes, adherence-focused packaging design and placebo-response mitigation.
Accelerating an ongoing Phase II trial
7 sites. 3 countries. 20 participants. Internal stakeholder consultations exposed hidden barriers, clarified accountability and accelerated delivery.
Ready to improve your trial design?
Whether you are in early protocol development or managing a challenging recruitment situation, we would be delighted to hear from you.